Critical PDT Theory III: Events at the Molecular and Cellular Level

Photodynamic therapy (PDT) is capable of eradicating neoplastic cells that are accessible to sufficient light and oxygen. There is adequate information now available for assessing conditions where PDT might be the therapy of choice, but limited access to clinical facilities and impediments to regulatory approval of new agents have limited clinical usage. Early reports mainly involved clinical data with few thoughts towards finding death pathways. In 2022, there is a clear understanding of the determinants of successful tumor eradication. While PDT may be the optimal method for many clinical indications, support for this approach has lagged. This report provides a commentary on some elements of recent progress in PDT at the molecular and cellular levels, along with a discussion of some of the limitations in current research efforts.

Automated summary

Photodynamic therapy (PDT) is capable of eradicating neoplastic cells accessible to sufficient light and oxygen. Despite adequate information available for assessing the conditions where PDT might be the therapy of choice, limited access to clinical facilities and barriers to regulatory approval of new agents have restricted its clinical usage.